52 Week Range
As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Blackmores H1 Revenue Rose 4 Percent To A$302.6 Million
Blackmores HY Revenue From Ordinary Activities $302.6 Mln
Blackmores Sees H1 FY21 Net Sales Growth In Mid-Single Digits Range
Blackmores Limited is an Australia-based company that is engaged in the development, sales and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. The Company's segments include ANZ, China, BioCeuticals Group and international. The Company’s brands include Blackmores- a natural health brand; BioCeuticals - a practitioner range; Impromy - its pharmacy based weight management program developed in collaboration with the Commonwealth Scientific and Industrial Research Organization (CSIRO), and Pure Animal Wellbeing - natural health products for pets.
Biotechnology & Drugs
20 Jubilee Ave
Chief Executive Officer, Managing Director, Executive Director
Group Chief Financial Officer
Chief Operations Officer
Chief People Officer
Chief Information Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Australian vitamin maker Blackmores Ltd on Tuesday scrapped its final dividend and said it would cut around 100 jobs after a two-third drop in annual profit, as sales in China, its biggest overseas market, were hit by the coronavirus outbreak.
Australia's Blackmores Ltd on Tuesday scrapped its final dividend and reported a 66.2% slump in full-year profit as the coronavirus crisis disrupted the vitamin maker's supply chain and hit sales to China.
* Shares lift 1.9% to one-week high (Recasts adding market reaction, quotes from analyst and management)
Australian vitamin maker Blackmores Ltd on Tuesday reported a 14.3 percent fall in net profit for the first nine months, as the company continues to grapple with softening demand from its largest Asian market, China.
* Shares mark biggest daily percentage drop since 1985 listing (Recasts on China review, updates shares)
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.